Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents.

Michael S. Lee, David R. Rutledge, Tae‐Hyun Yang(Inje University Busan Paik Hospital), Hyo‐Soo Kim(Inje University Ilsan Paik Hospital), George Dangas(Mount Sinai Hospital), Moo Hyun Kim(Yonsei University), James Hermiller(St. Vincent Hospital), Kyung Woo Park(Seoul National University Hospital), Mitchell W. Krucoff(Duke University), Ehtisham Mahmud(Cardiovascular Institute of the South)

PubMed

September 1, 2014

Cited by 6

Related Papers

Clinical End Points in Coronary Stent Trials

|Circulation|2007|5.4k

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

|European Heart Journal|2011|1.2k

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

|Circulation|2018|926

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

|The Lancet|2018|781

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

|The Lancet|2017|739